Kaji, Ryuji et al "Ultra-high dose methylcobalamin (E0302) prolongs survival of ALS: Report of 7 years’ randomised double-blind, phase 3 clinical trial (ClinicalTrials.gov NCT00444613) (P7.060)." Neurology 84.14 Supplement (2015): P7.060. Web. 20 Oct. 2019.